IM Cannabis Corp. (IMCC) stock declined over -9.17%, trading at $0.12 on NASDAQ, down from the previous close of $0.13. The stock opened at $0.12, fluctuating between $0.11 and $0.13 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 24, 2026 | 0.12 | 0.13 | 0.11 | 0.12 | 68.9M |
| Jul 23, 2026 | 0.14 | 0.14 | 0.13 | 0.13 | 207.29K |
| Jul 22, 2026 | 0.14 | 0.14 | 0.13 | 0.14 | 150.36K |
| Jul 21, 2026 | 0.13 | 0.14 | 0.13 | 0.14 | 343.59K |
| Jul 20, 2026 | 0.14 | 0.14 | 0.13 | 0.13 | 319.41K |
| Jul 17, 2026 | 0.13 | 0.15 | 0.13 | 0.14 | 237.99K |
| Jul 16, 2026 | 0.14 | 0.15 | 0.14 | 0.14 | 204.64K |
| Jul 15, 2026 | 0.15 | 0.15 | 0.14 | 0.15 | 322.37K |
| Jul 14, 2026 | 0.14 | 0.15 | 0.13 | 0.14 | 642.35K |
| Jul 13, 2026 | 0.15 | 0.15 | 0.14 | 0.15 | 391.33K |
| Jul 10, 2026 | 0.16 | 0.16 | 0.16 | 0.16 | 181.83K |
| Jul 09, 2026 | 0.16 | 0.17 | 0.15 | 0.16 | 322.11K |
| Jul 08, 2026 | 0.16 | 0.16 | 0.15 | 0.16 | 260.12K |
| Jul 07, 2026 | 0.15 | 0.16 | 0.14 | 0.16 | 317.72K |
| Jul 06, 2026 | 0.16 | 0.16 | 0.14 | 0.15 | 314.39K |
| Jul 02, 2026 | 0.16 | 0.16 | 0.15 | 0.15 | 339.48K |
| Jul 01, 2026 | 0.16 | 0.16 | 0.15 | 0.16 | 642.21K |
| Jun 30, 2026 | 0.15 | 0.17 | 0.14 | 0.17 | 2.33M |
| Jun 29, 2026 | 0.15 | 0.16 | 0.14 | 0.15 | 464.5K |
| Jun 26, 2026 | 0.14 | 0.15 | 0.13 | 0.14 | 633K |
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
| Employees | 44 |
| Beta | 2.04 |
| Sales or Revenue | $48.80M |
| 5Y Sales Change% | 11.383% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep